Mendus: Positive safety read-out from VITAL-CML trial - Redeye
The positive readout today clears the way for the next stage of the trial and the start of a second trial in CML, the VITAL-TFR2 trial. We look forward to seeing the the molecular readouts from this trial.
ANNONS
The positive readout today clears the way for the next stage of the trial and the start of a second trial in CML, the VITAL-TFR2 trial. We look forward to seeing the the molecular readouts from this trial.
